Adaptimmune Therapeutics-ADRADAPY
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 76 institutions reported holding Adaptimmune Therapeutics-ADR (ADAPY) in their 13F filings, down 4 from Q1 2024. 7 opened new positions and 10 sold out. The largest holders were Matrix Capital Management Company, LP ($38.0M), EcoR1 Capital, LLC ($26.7M) and NEA Management Company, LLC ($16.7M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Adaptimmune Therapeutics-ADR
- CUSIP
- 00653A107
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $206K |
| Exits | 10 | $2.1M |
All 13F filers, Q1 2024 → Q2 2024: 3,267,795 shares bought and 11,370,272 shares sold, net −8,102,477 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 76 holders
| Matrix Capital Management Company, LP | 0.29% | No change | 38,974,185 | $38.0M |
| EcoR1 Capital, LLC | 0.82% | No change | 27,404,070 | $26.7M |
| NEA Management Company, LLC | 1.25% | No change | 17,079,778 | $16.7M |
| Baillie Gifford & Co. | 0.01% | Reduce -4.5% | 15,149,203 | $14.8M |
| Long Focus Capital Management, LLC | 1.25% | Add +15.6% | 12,346,417 | $12.0M |
| PFM Health Sciences, LP | 0.57% | Add +0.9% | 10,520,231 | $10.3M |
| MPM Asset Management LLC | 2.97% | No change | 5,555,461 | $5.4M |
| MPM Bioimpact LLC | 0.77% | No change | 5,095,912 | $5.0M |
| Bank of America Corp. | 0.00% | Reduce -0.3% | 4,653,325 | $4.5M |
| Rock Springs Capital Management LP | 0.07% | No change | 2,425,468 | $2.4M |
| Baker Bros. Advisors LP | 0.03% | Reduce -78.3% | 2,343,695 | $2.3M |
| Renaissance Technologies | 0.00% | Add +28.4% | 1,786,341 | $1.7M |
| Tang Capital Management LLC | 0.17% | Add +20.8% | 1,743,619 | $1.7M |
| FMR LLC | 0.00% | Reduce -2.4% | 1,690,481 | $1.6M |
| JPMorgan Chase & Co. | 0.00% | Add +13.4% | 1,037,238 | $1.0M |
| Millennium Management | 0.00% | Reduce -5.5% | 779,615 | $760K |
| Redmile Group, LLC | 0.04% | No change | 715,607 | $698K |
| Acuitas Investments, LLC | 0.28% | Add +0.5% | 541,201 | $528K |
| Morgan Stanley | 0.00% | Add +18.1% | 440,832 | $430K |
| Rathbones Group PLC | 0.00% | No change | 432,818 | $422K |
| State Street Corp. | 0.00% | Add +25.1% | 390,901 | $381K |
| DAFNA Capital Management LLC | 0.08% | No change | 341,064 | $333K |
| Key Client Fiduciary Advisors, LLC | 0.13% | Reduce -1.7% | 263,989 | $257K |
| Susquehanna International Group, LLP | 0.00% | Add +329.8% | 242,144 | $236K |
| LPL Financial LLC | 0.00% | Add +82.7% | 198,856 | $194K |
| BlackRock Inc. | 0.00% | Reduce -33.1% | 193,757 | $189K |
| Marshall Wace, LLP | 0.00% | Reduce -43.0% | 144,880 | $141K |
| Citadel Advisors | 0.00% | Reduce -41.4% | 142,891 | $139K |
| Geode Capital Management, LLC | 0.00% | No change | 117,909 | $115K |
| Marquette Asset Management, LLC | 0.02% | No change | 98,589 | $96K |
| Captrust Financial Advisors | 0.00% | Reduce -25.8% | 83,041 | $81K |
| Virtu Financial LLC | 0.01% | New | 79,239 | $77K |
| Jane Street Group, LLC | 0.00% | New | 75,576 | $74K |
| Wells Fargo & Company | 0.00% | Add +17.5% | 63,672 | $62K |
| Northern Trust Corp. | 0.00% | Reduce -9.8% | 51,861 | $51K |
| Barclays PLC | 0.00% | No change | 50,061 | $49K |
| Oppenheimer & Co. Inc. | 0.00% | Reduce -10.3% | 39,298 | $38K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | Add +8.9% | 35,102 | $34K |
| Invesco Ltd. | 0.00% | New | 34,743 | $34K |
| Group One Trading LLC | 0.00% | Add +52.2% | 34,037 | $33K |
| Two Sigma Advisers, LP | 0.00% | Reduce -27.7% | 33,337 | $33K |
| Main Street Financial Solutions, LLC | 0.00% | No change | 31,190 | $30K |
| CSS LLC | 0.01% | No change | 30,702 | $30K |
| DLK Investment Management, LLC | 0.01% | No change | 30,512 | $30K |
| Simon Quick Advisors, LLC | 0.00% | No change | 30,000 | $29K |
| Janney Montgomery Scott LLC | 0.00% | No change | 30,000 | $29K |
| Columbia Advisory Partners LLC | 0.03% | Add +80.2% | 28,087 | $27K |
| Stifel Financial Corp. | 0.00% | Add +16.1% | 27,619 | $27K |
| JTC Employer Solutions Trustee Ltd | 0.00% | No change | 26,156 | $26K |
| Prosperity Wealth Management, Inc. | 0.01% | No change | 26,620 | $26K |
| HSBC Holdings PLC | 0.00% | No change | 26,064 | $26K |
| Hunter Associates Investment Management LLC | 0.00% | No change | 23,000 | $22K |
| Commonwealth Equity Services, LLC | 0.00% | Add +23.6% | 20,195 | $20K |
| Rhumbline Advisers | 0.00% | Add +134.8% | 16,721 | $16K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -85.0% | 16,119 | $16K |
| Osaic Holdings, Inc. | 0.00% | Reduce -20.8% | 15,258 | $15K |
| Vontobel Holding Ltd. | 0.00% | Reduce -43.5% | 13,000 | $13K |
| XTX Topco Ltd | 0.00% | Reduce -22.3% | 12,399 | $12K |
| X-Square Capital, LLC | 0.00% | No change | 11,192 | $10K |
| Raymond James & Associates | 0.00% | New | 10,218 | $10K |
| Wetzel Investment Advisors, Inc. | 0.01% | No change | 6,000 | $9K |
| Baader Bank Aktiengesellschaft | 0.00% | New | 10,287 | $8K |
| Global Retirement Partners, LLC | 0.00% | No change | 6,000 | $6K |
| Lindbrook Capital, LLC | 0.00% | Reduce -31.6% | 4,610 | $4K |
| CIBC Private Wealth Group LLC | 0.00% | Reduce -96.1% | 3,023 | $4K |
| Quadrant Capital Group LLC | 0.00% | Reduce -48.5% | 3,218 | $3K |
| IFP Advisors, Inc | 0.00% | New | 3,023 | $3K |
| UBS Group AG | 0.00% | Reduce -99.1% | 1,817 | $2K |
| Sandy Spring Bank | 0.00% | No change | 1,050 | $1K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 785 | $765 |
| Carmichael Hill & Associates, Inc. | 0.00% | No change | 525 | $512 |
| HighMark Wealth Management LLC | 0.00% | No change | 287 | $280 |
| Parallel Advisors, LLC | 0.00% | New | 250 | $244 |
| BNP Paribas Financial Markets | 0.00% | No change | 213 | $208 |
| Investors Research Corp | 0.00% | No change | 100 | $97 |
| National Bank of Canada | 0.00% | No change | 10 | $10 |
"% of holder's portfolio" is ADAPY's weight in each manager's 13F, not the share of Adaptimmune Therapeutics-ADR the manager owns.